Guardian Pharmacy Services, INC Form 4 insider transactions
NYSE
David K. Morris, an executive at Guardian Pharmacy Services, converted 641,869 shares of Class B common stock into Class A common stock on March 28, 2025, according to a recent SEC filing.
NYSE
John Ackerman, a director of Guardian Pharmacy Services, reported the conversion of Class B common stock into Class A common stock, as per the company's Amended and Restated Certificate of Incorporation.
NYSE
Kendall Forbes, an executive at Guardian Pharmacy Services, converted 608,570 shares of Class B common stock into Class A common stock on March 28, 2025, according to a Form 4 filing.
NYSE
Kendall Forbes, an Executive Vice President at Guardian Pharmacy Services, acquired 10,385 restricted stock units on February 5, 2025, which will vest into Class A common stock on February 5, 2028.
NYSE
David K. Morris, an executive at Guardian Pharmacy Services, was granted 10,385 restricted stock units that will vest in full on February 5, 2028.
NYSE
Director Steven D. Cosler purchased 7,000 shares of Guardian Pharmacy Services Class A Common Stock at a weighted average price of $21.22.
NYSE
Director William E. Bindley reports acquiring 24,400,702 shares of Class B Common Stock in Guardian Pharmacy Services due to a merger agreement.
NYSE
David K. Morris, Executive Vice President and CFO of Guardian Pharmacy Services, reports acquiring 2,567,477 shares of Class B Common Stock following a merger agreement.
NYSE
Fred Burke, a director and officer of Guardian Pharmacy Services, reports acquiring 5,195,303 shares of Class B common stock as a result of a merger agreement.
NYSE
Director John Ackerman reports acquisition of Class B Common Stock in Guardian Pharmacy Services following a merger, convertible to Class A Common Stock over time.
NYSE
Thomas J. Salentine Jr., a director of Guardian Pharmacy Services, acquired shares of Class A and Class B common stock through a directed share program and a merger agreement.
NYSE
Mary Sue Patchett, a director at Guardian Pharmacy Services, acquired shares of Class A Common Stock through a directed share purchase program and received restricted stock units in connection with the company's initial public offering.
NYSE
Kendall Forbes, an executive at Guardian Pharmacy Services, acquired shares of Class B Common Stock as part of a merger agreement.
NYSE
Director Randall J Lewis reports acquisition of Class A Common Stock through a directed share purchase and receipt of restricted stock units in Guardian Pharmacy Services, Inc.
NYSE
Director Steven D. Cosler purchased shares and received restricted stock units in Guardian Pharmacy Services' initial public offering.